Literature DB >> 25040651

Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.

P Zezos1, K Patsiaoura, A Nakos, A Mpoumponaris, T Vassiliadis, O Giouleme, M Pitiakoudis, G Kouklakis, N Evgenidis.   

Abstract

AIM: Eosinophils are potent proinflammatory cells that are involved in the pathogenesis of ulcerative colitis (UC). We evaluated the infiltration of eosinophils into the lamina propria in patients with active and inactive ulcerative colitis (UC) and investigated its clinical significance, among other variables, in predicting the outcome of medical treatment in active disease.
METHOD: We studied colorectal biopsy specimens from 18 UC patients with disease in long-standing remission, from 22 patients with active disease who responded to therapy (12 with complete response and 10 with partial response) and from 10 patients who were nonresponders. Demographic information was obtained at baseline, and clinical, endoscopic and laboratory data were obtained at baseline and 12 weeks post-treatment. We evaluated five histological features: mucosal ulceration; mucosal erosions; crypt abscesses; cryptitis; and eosinophilic infiltration of the lamina propria. The severity of these lesions was graded as: none or minimal; mild; moderate; or severe. Statistical analyses were performed between responders and nonresponders for differences in demographic, clinical, laboratory, endoscopic and histological parameters.
RESULTS: Laboratory, endoscopic and histological parameters were significantly improved after treatment only in the complete responders group. Analyses of baseline data revealed no significant differences in parameters between complete or partial responders and nonresponders, except for a less severe eosinophilic infiltration of lamina propria in complete responders (P < 0.05). Multiple logistic regression analysis showed that severe eosinophilic infiltration in colonic biopsies was the most significant predictor of poor response to medical therapy.
CONCLUSION: Assessing the severity of eosinophilic infiltration in the lamina propria of colonic biopsies in patients with ulcerative colitis could be a valuable predictive tool of response to medical therapy. Colorectal Disease
© 2014 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Eosinophils; colonic histology; inflammatory bowel disease; predictive value; ulcerative colitis; ulcerative colitis treatment

Mesh:

Substances:

Year:  2014        PMID: 25040651     DOI: 10.1111/codi.12725

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  16 in total

1.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

2.  Classification of eosinophilic disorders of the small and large intestine.

Authors:  Aoife J McCarthy; Kieran Sheahan
Journal:  Virchows Arch       Date:  2017-11-10       Impact factor: 4.064

3.  A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.

Authors:  Alina Kurolap; Orly Eshach Adiv; Liza Konnikova; Lael Werner; Claudia Gonzaga-Jauregui; Maya Steinberg; Vanessa Mitsialis; Adi Mory; Moran Y Nunberg; Sarah Wall; Ron Shaoul; John D Overton; Alan R Shuldiner; Yaniv Zohar; Tamar Paperna; Scott B Snapper; Dror S Shouval; Hagit Baris Feldman
Journal:  J Clin Immunol       Date:  2019-05-11       Impact factor: 8.317

Review 4.  Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections.

Authors:  Pooja Mehta; Glenn T Furuta
Journal:  Immunol Allergy Clin North Am       Date:  2015-06-17       Impact factor: 3.479

Review 5.  Machine Learning Predictive Outcomes Modeling in Inflammatory Bowel Diseases.

Authors:  Aamir Javaid; Omer Shahab; William Adorno; Philip Fernandes; Eve May; Sana Syed
Journal:  Inflamm Bowel Dis       Date:  2022-06-03       Impact factor: 7.290

6.  An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.

Authors:  Christopher Ma; Rocio Sedano; Ahmed Almradi; Niels Vande Casteele; Claire E Parker; Leonardo Guizzetti; David F Schaeffer; Robert H Riddell; Reetesh K Pai; Robert Battat; Bruce E Sands; Christophe Rosty; Marla C Dubinsky; Florian Rieder; Noam Harpaz; Maria T Abreu; Robert V Bryant; Gregory Y Lauwers; Richard Kirsch; Mark A Valasek; Eileen Crowley; William J Sandborn; Brian G Feagan; Rish K Pai; Vipul Jairath
Journal:  Gastroenterology       Date:  2021-02-19       Impact factor: 22.682

Review 7.  Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD).

Authors:  Vincenzo Villanacci; Luca Reggiani-Bonetti; Tiziana Salviato; Giuseppe Leoncini; Moris Cadei; Luca Albarello; Alessandro Caputo; Maria Costanza Aquilano; Serena Battista; Paola Parente
Journal:  Pathologica       Date:  2021-02

Review 8.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

9.  Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study.

Authors:  Triana Lobatón; Talat Bessissow; Alexandra Ruiz-Cerulla; Gert De Hertogh; Raf Bisschops; Jordi Guardiola; Gert Van Assche; Severine Vermeire; Marc Ferrante
Journal:  United European Gastroenterol J       Date:  2018-01-08       Impact factor: 4.623

10.  Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.

Authors:  Maria Carolina S Mendes; Daiane Sm Paulino; Sandra R Brambilla; Juliana A Camargo; Gabriela F Persinoti; José Barreto C Carvalheira
Journal:  World J Gastroenterol       Date:  2018-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.